sirolimus and Histiocytosis

sirolimus has been researched along with Histiocytosis* in 1 studies

Other Studies

1 other study(ies) available for sirolimus and Histiocytosis

Article	Year
Treatment of benign cephalic histiocytosis with topical 1% rapamycin ointment. Pediatric dermatology, 2019, Volume: 36, Issue:3 We report a pediatric case of extensive, progressive benign cephalic histiocytosis (BCH) involving the face, trunk, and extremities with response of facial lesions to treatment with topical 1% rapamycin. A split-face model was used to demonstrate improvement on the treated side versus the untreated side. After physician and parental perception of effectiveness, based in part on photodocumentation, subsequently both cheeks were treated with continued improvement. Topics: Administration, Cutaneous; Child, Preschool; Facial Dermatoses; Histiocytosis; Humans; Immunosuppressive Agents; Male; Ointments; Sirolimus	2019

Article

Year

Treatment of benign cephalic histiocytosis with topical 1% rapamycin ointment.

Pediatric dermatology, 2019, Volume: 36, Issue:3

We report a pediatric case of extensive, progressive benign cephalic histiocytosis (BCH) involving the face, trunk, and extremities with response of facial lesions to treatment with topical 1% rapamycin. A split-face model was used to demonstrate improvement on the treated side versus the untreated side. After physician and parental perception of effectiveness, based in part on photodocumentation, subsequently both cheeks were treated with continued improvement.

Topics: Administration, Cutaneous; Child, Preschool; Facial Dermatoses; Histiocytosis; Humans; Immunosuppressive Agents; Male; Ointments; Sirolimus

2019